Breast Cancer News and Research

Latest Breast Cancer News and Research

Femara shows reduced risk of death versus tamoxifen after breast cancer surgery

Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.

14 Dec 2008

Exciting cancer discovery

Metastasis is the ability of cancer cells to spread from a primary site, to form tumours at distant sites.

14 Dec 2008

Early-stage breast cancer patients with HER2 positive tumors at increased risk of recurrence

Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.

14 Dec 2008

Atypical hyperplasia increases risk of developing breast cancer

A type of benign breast disease (BBD) known as atypical hyperplasia substantially increases a young woman's risk of developing breast cancer, even if there is no history of breast cancer in her family, say researchers at Mayo Clinic.

14 Dec 2008

Magnetic resonance imaging alternated with mammography may be best for high-risk women

Magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast cancers not identified by mammography alone, a research team from The University of Texas M. D. Anderson Cancer Center will report at the 31st at the CRTC-AACR San Antonio Breast Cancer Symposium.

14 Dec 2008

Aromatase inhibitors most effective in preventing breast cancer from coming back

Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back.

12 Dec 2008

Researchers find tamoxifen's power comes from endoxifen

Mayo Clinic researchers have discovered that a chemical known as endoxifen appears to be the primary metabolite responsible for the effectiveness of tamoxifen in treating breast cancer, and that it works against cancer in an entirely unexpected way.

12 Dec 2008

Estrogen therapy can help control metastatic breast cancer

For breast cancer survivors, the idea of taking estrogen pills is almost a taboo. In fact, their doctors give them drugs to get rid of the hormone because it can fuel the growth of breast cancer.

12 Dec 2008

PreMD files provisional patent application for new method of quantifying cancer biomarkers

Predictive medicine company PreMD Inc. has announced that it has filed a provisional patent application that describes a new simplified method of quantifying immunohistochemical staining of biomarkers. The provisional patent application was filed with the United States Patent and Trademark office.

11 Dec 2008

Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer

Nonhormonal treatment regimens, including anthracycline-based regimens and taxanes, have improved overall survival in women with advanced (metastatic or recurrent inoperable) breast cancer over the last 35 years, according to a systematic review published December 9 in the Journal of the National Cancer Institute.

10 Dec 2008

UK kidney cancer patients face toxic, out-dated treatments with little hope of change

Leading oncologist Professor Tim Eisen has expressed concerns that patients with advanced kidney cancer could be condemned to toxic, barely effective, 20 year-old treatments because the National Institute for Health and Clinical Excellence (NICE) is likely to rule out using all four of the new treatments it has assessed.

10 Dec 2008

Overweight children may inherit faster eating behaviour

Overweight children may inherit faster eating behaviour according to a Cancer Research UK study published in the American Journal of Clinical Nutrition.

10 Dec 2008

Conquering cancer: A global effort

Despite the recent good news that cancer incidence and death rates for men and women in the United States continue to decline, cancer is projected to become the leading cause of death worldwide in the year 2010, and low- and middle-income countries will feel the impact of higher cancer incidence and death rates more sharply than industrialized countries.

10 Dec 2008

Untimely death of Kerryn McCann a stark warning

The revelation that champion marathon runner Kerryn McCann did nothing for months after discovering a lump in her breast, is a stark warning to women to heed any changes they notice in their breasts and seek medical advice.

9 Dec 2008

Mammography screening in women over 80

A lack of clear-cut, scientific evidence illustrating the benefits of mammography screening in women over 80 has created a trail of controversy leading to a disturbing conclusion about cancer care in America.

8 Dec 2008

Relationship woes hinder breast cancer recovery

Breast cancer patients who have a poor relationship with their spouse may face a more difficult road to recovery than would other women, according to a new study.

8 Dec 2008

Networks of interactive genes may predict Leukemia's development

Rather than testing for individual marker genes or proteins, researchers at the University of California, San Diego (UC San Diego) and the Moores UCSD Cancer Center have evidence that groups, or networks, of interactive genes may be more reliable in determining the likelihood that a form of leukemia is fast-moving or slow-growing.

8 Dec 2008

Discovery of protein that may cause breast cancer to spread

In an important finding published online in Developmental Cell , researchers at Albert Einstein College of Medicine of Yeshiva University, along with collaborators at Massachusetts Institute of Technology, have identified a protein likely responsible for causing breast cancer to spread.

8 Dec 2008

Confusing risk information may lead breast cancer patients to make poor treatment choices

A new study from researchers at the University of Michigan Comprehensive Cancer Center found that a tool commonly used by doctors to estimate the risk of a woman's breast cancer returning after surgery is not very effective at explaining risk to patients.

8 Dec 2008

Glowing imaging compound allows detection of viable cancer cells in mice

Researchers have developed a new type of imaging compound that allows them to visualize viable breast cancer cells that have spread to the lungs in mice.

8 Dec 2008

Breast Cancer News and Research

Latest Breast Cancer News and Research

Femara shows reduced risk of death versus tamoxifen after breast cancer surgery

Exciting cancer discovery

Early-stage breast cancer patients with HER2 positive tumors at increased risk of recurrence

Atypical hyperplasia increases risk of developing breast cancer

Magnetic resonance imaging alternated with mammography may be best for high-risk women

Aromatase inhibitors most effective in preventing breast cancer from coming back

Researchers find tamoxifen's power comes from endoxifen

Estrogen therapy can help control metastatic breast cancer

PreMD files provisional patent application for new method of quantifying cancer biomarkers

Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer

UK kidney cancer patients face toxic, out-dated treatments with little hope of change

Overweight children may inherit faster eating behaviour

Conquering cancer: A global effort

Untimely death of Kerryn McCann a stark warning

Mammography screening in women over 80

Relationship woes hinder breast cancer recovery

Networks of interactive genes may predict Leukemia's development

Discovery of protein that may cause breast cancer to spread

Confusing risk information may lead breast cancer patients to make poor treatment choices

Glowing imaging compound allows detection of viable cancer cells in mice

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Breast Cancer News and Research

Latest Breast Cancer News and Research

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in